>
Switch to:

Allergy Therapeutics EPS (Basic)

: $0.00 (TTM As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's basic earnings per share (Basic EPS) for the six months ended in Jun. 2021 was $-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00.

Allergy Therapeutics's EPS (Diluted) for the six months ended in Jun. 2021 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00.

Allergy Therapeutics's EPS without NRI for the six months ended in Jun. 2021 was $-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2021 was 0.00.

During the past 12 months, Allergy Therapeutics's average EPS without NRIGrowth Rate was -63.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Allergy Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 66.90% per year. The lowest was -100.00% per year. And the median was -18.15% per year.


Allergy Therapeutics EPS (Basic) Historical Data

The historical data trend for Allergy Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
EPS (Basic)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 0.01 0.01 0.01

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
EPS (Basic) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.03 -0.02 0.03 -0.03

Allergy Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Allergy Therapeutics's Basic EPS for the fiscal year that ended in Jun. 2021 is calculated as

Basic EPS (A: Jun. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.0476858345021-0)/639.190
=0.01

Allergy Therapeutics's Basic EPS for the quarter that ended in Jun. 2021 is calculated as

Basic EPS (Q: Jun. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-16.904628330996-0)/641.094
=-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Allergy Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)